Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 95,349

Document Document Title
WO/2017/027490A1
Embodiments include a biological growth device, and related methods for growing biofilms using embodiments of such biological growth device. The device includes a channel configured to convey a fluid medium. A first coupon well is dispos...  
WO/2017/024372A1
The present invention relates to a method for producing a continuous cell line of embryonic-like stem cells, for example from Amblyomma sculptum (Acari: Ixodidae), designated as IBU/ASE-16 (access number in the CNCM: I-5000), and to the ...  
WO/2017/026635A1
The present invention relates to a composition for an animal feed comprising a Lactobacillus sp. strain or dead cells thereof, and a method for producing dead cells of the Lactobacillus sp. strain.  
WO/2017/027723A1
Disclosed herein are methods and compositions for the delivery of polypeptides, including vaccine candidate polypeptides, into mammalian cells comprising the use of photosensitized trypanosomatid organisms. Also disclosed are methods of ...  
WO/2017/026331A1
Provided is an active ingredient of a pharmaceutical composition for myeloma therapy. This antibody has an epitope in a region comprising the 20th to 109th amino acid residues of human integrin β7.  
WO/2017/025649A1
A recombinant host capable of producing a steviol glycoside which overexpresses a polypeptide which mediates steviol glycoside transport and which polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 35 or SEQ ID NO: 38 ...  
WO/2017/022740A1
A lipid production method for cultivating a transformant having enhanced expression of a gene encoding protein (A) or (B) below, and producing long-chain fatty acids or a lipid having the same as components. (A) Protein comprising an ami...  
WO/2017/024059A1
Disclosed herein are methods of terminally sterilizing bacterial niinicells or compositions comprising bacterial niinicells by exposure to ionizing irradiation. Also disclosed are terminally sterilized bacterial niinicells, pharmaceutica...  
WO/2017/022804A1
In order to provide a method whereby an olefin compound can be manufactured with high productivity and to provide an enzyme for use in the method, the inventors introduced variations involving amino acid substitution at various sites of ...  
WO/2017/023801A1
Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.  
WO/2017/021754A1
The present invention provides methods for the preparation of fermented food products comprising Bifidobacteria comprising the use of manganese. The present invention further provides products prepared by means of such a method as well a...  
WO/2017/022583A1
Provided is a promoter suitable for the high-level expression of a gene of interest. A promoter comprising DNA selected from the group consisting of DNA molecules (a) to (d): (a) DNA which comprises a nucleotide sequence represented by a...  
WO/2017/020785A1
An application of bacteroides fragilis in animal breeding, an application of the bacteroides fragilis in preventing and/or treating gastrointestinal diseases of animals, and an application thereof in pharmaceutical compositions and feed ...  
WO/2017/021931A1
The present invention falls within the field of biotechnologies and relates to a method for concentrating a cell suspension comprising a mucilaginous biomass of oleaginous yeasts. More specifically, the present invention relates to a met...  
WO/2017/020783A1
Provided is an application of bacteroides fragilis in prevention and/or treatment of meningitis, in particular, an application of the bacteroides fragilis in preparation of medicines, pharmaceutical compositions, food, health care produc...  
WO/2017/023070A1
The present invention relates to extracellular polysaccharides produced by Ceriporia lacerate, a mycelial culture broth of Ceriporia lacerate, containing the extracellular polysaccharides, a composition for promoting fatigue recovery con...  
WO/2017/023818A1
The present disclosure provides engineered bacterial cells comprising a heterologous gene encoding a propionate catabolism enzyme. In another aspect, the engineered bacterial cells further comprise at least one heterologous gene encoding...  
WO/2017/022587A1
A lipid production method for cultivating a transformant having enhanced expression of a gene encoding protein (A) or (B) below and producing fatty acids or a lipid having the same as structural components. (A) Protein comprising an amin...  
WO/2017/022856A1
The invention provides an alternative method for producing an isoprene monomer. Specifically, the present invention is a method for producing an isoprene monomer including the production of an isoprene monomer from dimethylallyl diphosph...  
WO/2017/022759A1
The present invention provides an antibody-binding protein having improved culture productivity in a genetic recombinant. The present invention relates to a protein that comprises two or more amino acid sequences derived from the E, D, A...  
WO/2017/020784A1
Provided are a bacteroides fragilis and an application thereof, and in particular, a bacteroides fragilis ZY-312 with a preservation number of CGMCC No. 10685, and an application of the bacteroides fragilis in preparation of medicines, p...  
WO/2017/024313A1
Disclosed are methods for producing steviol glycosides, such as rebaudioside D and rebaudioside M, using engineered yeast. The methods include growing yeast on non-fermentative carbon sources. Other methods include growing yeast on one o...  
WO/2017/020853A1
Disclosed is a solid state biological reaction device, comprising a main tank (1), wherein the device further comprises a support (2) supporting the main tank (1), and the support (2) makes the main tank (1) be rotational in the horizont...  
WO/2017/020839A1
Provided are a heterologous expression and use of a good quality D-acetylglucosamine deacetylase. The D-acetylglucosamine deacetylase has an amino acid sequence as shown in SEQNO.1. An analysis on an assay on enzyme activity and substrat...  
WO/2017/022672A1
The purpose of the present invention is to provide an immunoglobulin-binding modified protein for the production of an affinity separation matrix having high antibody binding capacity. The present invention provides a protein that compri...  
WO/2017/019125A1
The present invention provides a protein material and food ingredient from a sustainable and stable source. The sustainable and stable source of the food or food ingredient is cellular biomass, for example an algal or microbial biomass. ...  
WO/2017/017662A1
Invention concerns a microorganism strain Lactobacillus Plantarum LS/07 CCM 7766 and a method of its use for the purposes of adjustment and stabilization of healthy intestinal microflora of a man. Microorganism strain Lactobacillus Plant...  
WO/2017/017355A1
The invention relates to a microbiological method for producing formate from CO2 catalysed by a type II methanotrophic bacterium, particularly by the bacterium Methylosinus trichosporium OB3b. The invention also relates to a method for t...  
WO/2017/018288A1
Provided is a new means for effectively treating diseases including autoimmune diseases and the like. This peptide fragment has an amino acid sequence from position 46 to position 73, an amino acid sequence from position 160 to position ...  
WO/2017/017439A1
The invention provides a diagnostic kit comprising means to determine the presence in a sample of preferred strains the nitrogen-fixing bacteria Gluconacetobacter diazotrophicus(Gd) which are based upon the finding that such strains comp...  
WO/2017/018471A1
Provided are the following: the construction of a filamentous fungus mutant strain with which the interference with enzyme production that is attributed to glucose is inhibited; a method for producing a glycolytic enzyme using the filame...  
WO/2017/019633A2
The disclosure relates to isolated microorganisms-including novel strains of the microorganisms-microbial consortia, and agricultural compositions comprising the same. Furthermore, the disclosure teaches methods of utilizing the describe...  
WO/2017/019633A3
The disclosure relates to isolated microorganisms-including novel strains of the microorganisms-microbial consortia, and agricultural compositions comprising the same. Furthermore, the disclosure teaches methods of utilizing the describe...  
WO/2017/020043A2
This disclosure generally relates to the use of microorganisms to make various functionalized polyketides through polyketoacyl-CoA thiolase-catalyzed non-decarboxylative condensation reactions instead of decarboxylative reactions catalyz...  
WO/2017/017440A1
A strain of Gluconacetobacter diazotrophicus (Gd) characterised by the presence of at least one nucleic acid sequence selected from SEQ ID NOS 1-10 or variants or paralogues thereof and/or the presence of a single plasmid of about 17566 ...  
WO/2017/017830A1
This bioreactor and the bioreaction method that uses the bioreactor address the problems of reducing the stress/damage incurred by a microorganism or the like during a bioreaction and of making it possible to efficiently and economically...  
WO/2017/017188A1
The invention relates to an isolated strain of Sporobolomyces roseus with high carotenoid production capacity. There are also disclosed processes for obtaining colored compositions comprising carotenoids and in particular β-carotene. Th...  
WO/2017/018863A1
The present invention relates to a hexuronate C4-epimerase mutant having improved conversion activity of hexuronate C4-epimerase, and a method for producing tagatose using the same.  
WO/2017/019448A1
Methods for improving the ability of a population of biological agents to compete and survive in a field setting are provided. The improved, modified population of agents is able to grow, compete with other microbial strains and fungi, a...  
WO/2017/018440A1
The present invention provides a lactobacillus composition that contains lactobacillus of at least a prescribed type and that is used for fermenting a milk raw material.  
WO/2017/017263A1
There is described herein a consortium of micro-organisms comprising, consisting or consisting essentially of Rhizobium spp., Bacillus spp., and Pseudomonas spp.  
WO/2017/017662A4
Invention concerns a microorganism strain Lactobacillus Plantarum LS/07 CCM 7766 and a method of its use for the purposes of adjustment and stabilization of healthy intestinal microflora of a man. Microorganism strain Lactobacillus Plant...  
WO/2017/017998A1
This bioreactor and the bioreaction method that uses the bioreactor address the problems of reducing the stress/damage incurred by a microorganism or the like during a bioreaction and of making it possible to efficiently and economically...  
WO/2017/013335A1
The invention relates to a method for extracting carboxylic acids having between one and nine carbon atoms, produced by microorganisms (M) in a fermentation reactor (1) via anaerobic fermentation from fermentable biomass (S), said extrac...  
WO/2017/013695A1
[Problem] To provide a disposal method, preferably a utilization method, of a waste sugar alcohol solution with little environmental load. Yeast cells are produced using, as a sugar source, a sugar alcohol such as maltitol or sorbitol wh...  
WO/2017/014259A1
The invention provides a protein A ligand having reduced antibody-binding capacity in the acidic pH region when immobilized on a carrier to form an affinity separation matrix. The invention provides a protein including an amino acid sequ...  
WO/2017/015368A1
Recombinant microbial cells comprising an engineered LCDA production pathway that comprises at least one up-regulated long-chain acyl-CoA synthetase (ACoS) are disclosed. These recombinant microbial cells are capable of producing one or ...  
WO/2017/015320A1
Embodiments disclosed here provide engineered modified hematopoietic stem cells (HSCs), artificially prostaglandin E2 (PGE2)-stimulated HSCs, compositions comprising these HSCs, methods of using these modified HSCs for treating autoimmun...  
WO/2017/012571A1
Provided is a use of a Bacillus coagulans strain in increasing egg production in a laying hen. The Bacillus coagulans is combined with a Bacillus subtilis (CCTCC No. M2011443) and a Bacillus licheniformis (CCTCC No. M2012458) to obtain a...  
WO/2017/014175A1
Provided is a microorganism exhibiting high productivity of sophorolipids. A sophorolipid highly-productive yeast mutant strain in which a transporter transporting Acyl-CoA to a peroxisome has been deleted or deactivated.  

Matches 151 - 200 out of 95,349